Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
Clinical trial NCT06752694 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06752694
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2026-01-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.